Targeting the ATR-Chk1 axis with PARP inhibition results in tumor regression in BRCA mutant models
George, E., Kim, H., Ragland, R., Rafail, S., Zhang, R., Krepler, C., Morgan, M.A., Herlyn, M., Brown, E., Simpkins, F.Volume:
145
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2017.03.236
Date:
June, 2017
File:
PDF, 56 KB
english, 2017